Vivax Working Group (VxWG)


The aim of the Vivax Working Group (VxWG) is to develop and coordinate operational research that will provide the evidence base for the successful control and ultimate elimination of P. vivax in APMEN Country Partners and the greater Asia Pacific region.

Objectives:

  • Identify knowledge gaps and operational research priorities necessary for the optimal control and elimination of vivax malaria
  • Share research and operational experience  between APMEN Country Partners to maximise synergistic activities and minimise unnecessary duplication
  • e.g. study design, standard operating procedure and other research methodologies.
  • A document reviewing research activities, assets, collaborators currently being undertaken in Country Partners.
  • Fund catalytic research projects to address key knowledge gaps, and facilitate their implementation, analysis and feedback to the Network.
  • Develop partnerships with key stakeholder involved in the regional elimination for vivax malaria (including but not limited to WHO, Malaria Atlas Project (MAP), WorldWide Antimalarial Resistance Network (WWARN), Malaria Elimination Group (MEG), Foundation for Innovative New Diagnostics (FIND), Asian Vivax Network,  research institutions, funding bodies) in order to:
  • Facilitate surveillance strategies to define, monitor, and collate the burden of vivax in APMEN Country Partners.
  • Provide evidence for rational diagnostic and treatment guidelines for P. vivax.
  • Work with APMEN Country Partners and Partner Institutions to develop a series of integrated translational research programs, apply for external funding and facilitate their implementation.
  • Work through APMEN to advocate for improved funding of P.vivax control and research activities.
  • Promote collaborative research partnerships amongst APMEN Country Partners

New Report - Targeting vivax malaria in the Asia Pacific

The APMEN Vivax Working Group (VxWG) coordinating team has released a brand new report, 'Targeting vivax malaria in the Asia Pacific: 2009 - 2014', now available for download from the APMEN website.

Launched during the annual VxWG meeting in Cambodia in November 2014, the report is a milestone of the last five operating years of the VxWG, and highlights the coordinated efforts of many APMEN country partners and partner institutions, who have worked together to share the challenges and successes inP. vivax technical and research capacity with the common goal of a Malaria-Free Asia Pacific region.

Download the APMEN report, 'Targeting vivax malaria in the Asia Pacific: 2009 - 2014" here 

 (PDF 8,130KB)

Evidence Summaries

The November 2014 APMEN VxWG meeting also saw the launch of three evidence summaries, available for download:

Standardized evaluation of qualitative G6PD assays (138KB)
An update on the treatment of vivax malaria (260KB)
What molecular tools are being explored to map and identify imported cases? (115KB)

Country Partner Techincal Research Grants

As part of the APMEN Country Partner Techical Grant program, APMEN funded several projects under the 3 thematic areas of Diagnosis, Surveillance and Treatment. In total, 20 projects were funded for researchers from China (4), Republic of Korea (1), Indonesia (5), Sri Lanka (2), Malaysia (2), Bhutan (3), Philippines (1), Cambodia (1), and Vanuatu & the Solomon Islands (1).

To view/download the full complement of these research grant A3 posters, click here. (PDF 10,060kb)

--------------------------------------------------------------------------------------------------------------------------------------

Annual meeting webpages 

2015 APMEN-PATH Consultation - Manila, Philippines

2014 Vivax Working Group Meeting - Siem Riep, Cambodia / Manila, Philippines

2013 Vivax Working Group Meeting - Bali, Indonesia

2012 Vivax Working Group Meeting - Incheon, ROK

2011 Vivax Working Group Meeting - Kota Kinabalu, Malaysia


Vivax Working Group links

VxWG Objectives and Governance

VxWG Terms of Reference

Malaria Journal (2013, 12:112): Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report

Workshop Report - Planning a Multicentre Primaquine Trial, 26-28 September, 2011



Bangladesh
Bhutan
Cambodia
China
Democratic People’s Republic of Korea
Indonesia
Lao People’s Democratic Republic
Malaysia
Nepal
Philippines
Republic of Korea
Solomon Islands
Sri Lanka
Thailand
Vanautu
Vietnam